They made a whole lot of money in 2020. This included:
$84.9m in revenue from ERAS
$32.7m from the AMCAS
$27.1m from the MCAT
$14.4m from membership dues
$10.3m from workshops
3/
They have >875 employees. Most make (well) under $100k but the leadership does pretty well.
In 2019, the CEO made $1.6m.
Together the 20 highest compensated employees make over $12m/year.
To understand the proof you should read Dr Sheldricks post.
To summarize, he observed that in this non-randomized study the baseline characteristics of the pre & post intervention groups are far too perfectly matched. This perfect matching is unlikely to occur by chance.
2/
Specifically, you’d expect to see a range of p values for each baseline characteristic.
(This is especially true in a tiny trial with only n=47 patients)
Instead the range of p values for almost every variable was exactly 1.
This is *extremely* unlikely to occur by chance. 3/
Here’s a situation many of us have seen in the ICU or ED: “It looked like there was ST elevation on the monitor but when I took a 12 lead it was gone?!”
A STEMI went MIA? Here’s a #tweetorial all about why ST segments look different on monitors.
First, here’s another great example of "disappearing ST elevation", from Dr. Smith’s ECG Blog @smithECGBlog
(If you don’t already you should definitely follow Dr Smith & bookmark his site; hqmeded-ecg.blogspot.com IMO it's the best site for ECGs; you can thank me later) 2/
In order to understand *WHY* the ST segment looks different, we need to know how an ECG works & understand just a little bit of electronics & math.
(Don't worry, I promise no equations or circuit diagrams 🤞)
3/
This guy actually got both calculations completely wrong.
In the ACTIV6 trial an 80 kg person receiving 0.6 mg/kg of ivermectin would receive:
80 kg * 0.6 mg/kg = 48 mg per day
(Somehow he calculated 0.24 mg so he was off by 200x; another huge error 😱)
Bottom line:
- don’t take animal meds EVER; it’s very easy to make a fatal mistake
- don’t take medical advice from a guy with zero training who can’t multiply two numbers correctly
New embarrassingly bad study of ivermectin is a textbook example of “confounding by indication”
In short a retroactive database review found that people w/ COVID did worse if given remdesivir (only given to sick inpatients) than ivermectin (only given to well outpatients)🤔 1/
There are many problems with this “study”.
First it’s generous to even call it a “study.” It’s an *abstract* of a retrospective database review. The whole “article” is less than a page (see below).
They found 1.7 million people w/ COVID. Out of this group they identified 1,072 who received ivermectin (not exactly widely used) & 40k who received remdesivir
The groups were very dissimilar: IVM was 10 yrs younger. They don’t report any comorbidities 3/
In confronting COVID misinformation I’ve mostly focused on inpatient treatment (this is my area of experience).
Recently I saw the FLCCC Long COVID “protocol” & oh boy is this some crazy non-evidence based prescriptions: HIV meds, steroids, diuretics, & of course ivermectin… 1/
First off, Long COVID is definitely “real” & can be severe.
Many studies have found persistent changes in immune cell phenotype & function, months after COVID infection.
Many great docs (@WesElyMD & others) are actively researching long COVID to improve our understanding.
2/
What concerns me is FLCC presenting “protocols” as proven treatments for long COVID.
Throwing 20 medications (9 are prescription 🟥) at a problem with minimal (or no) evidence is irresponsible. nature.com/articles/s4159…
As we will see, this is both unethical & likely harmful. 3/